Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Victor Montori
With
Agency for Healthcare Research and Quality (AHRQ)
To determine the ability of decision aids to effectively translate a depression comparative effectiveness research (CER) review into practice, the investigators have developed a literacy-sensitive depression treatment decision aid, DEPRESSION MEDICATION CHOICE, which adapts the Agency for Healthcare Research and Quality (AHRQ)'s Effective Healthcare comparative effectiveness review and associated patient guide about antidepressant medicines to satisfy the needs of clinicians, patients, and other major stakeholders. The investigators will conduct a randomized study to estimate the effect of the decision aid on patient knowledge, patient involvement in decision making and decision-making quality, and on three and six-month measures of medication adherence and mental health, when compared with usual care.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Presumed diagnosis of depression (PHQ-9 of 10 or greater)
As judged by clinician, need to initiate drug treatment for depression
Identify primary care clinician as main depression provider
Agree to be available for follow-up survey 6 months after treatment decision
You may not be if
Has prior diagnosis of bipolar disorder
Has major communication barrier (severe hearing/vision impairment, dementia, cannot communicate with clinician in same language)